MeSH tree: E05.200.500.620
A new survey of U.S. physicians focuses on human preservation procedures and the feasibility of future revival. Ariel Zeleznikow-Johnston of Monash University, Australia, and colleagues present their findings in the study, ...
May 20, 2026
0
5
Platelets, which allow blood to clot, can save patients in danger of bleeding to death from traumatic injuries. But donated platelets can only be given to patients in a hospital and last only a few days at room temperature ...
Apr 28, 2026
0
5
An international team led by researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) and A*STAR Genome Institute of Singapore (A*STAR GIS), has published a paper in Nature Cancer ...
Mar 26, 2026
0
4
New research assessing the efficacy of optical genome mapping (OGM) in a group of patients with acute leukemia has demonstrated that OGM provided reliable and robust analytical performance with high sensitivity and specificity ...
Mar 11, 2026
0
8
Published, peer-reviewed research shows a patent-pending, virus-mimicking platform technology developed at Purdue University improves upon traditional methods of targeting bladder cancer cells with messenger RNA (mRNA) therapies.
Jan 18, 2026
0
30
It's not often that a pathologist gets to make a diagnosis that works for the patient by preventing treatment from occurring. But thanks to a Johns Hopkins Medicine doctor and his newly reported definition and classification ...
Dec 3, 2025
0
10
The precise identification of tumor boundaries during radical prostatectomy remains a major clinical challenge. As positive surgical margins occur in 15–40% of prostate cancer cases, the risk of postoperative recurrence and ...
Nov 24, 2025
0
14
A study from the University of Michigan Health Rogel Cancer Center and Department of Pathology shows that further testing in renal cell carcinoma with an overexpression of gene TRIM63 could uncover a mutation otherwise undetected, ...
Oct 29, 2025
0
22
The first malaria treatment for babies and very young children of 2 months up to 5 years was approved for use by Swiss agency for therapeutic products, Swissmedic, in early July 2025. Until now, babies and very young children ...
Jul 29, 2025
0
15
Dana-Farber research uncovered the potential for underdiagnosis of this aggressive cancer and identified additional tests required for an accurate diagnosis.
Jul 24, 2025
0
16
